搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
Glamour
3 小时
Hidradenitis Suppurativa Treatment: 5 Questions to Ask Your Doctor After a Hidradenitis ...
Getting a diagnosis of hidradenitis suppurativa (HS) can be overwhelming, especially if you’ve never heard of the condition ...
20 小时
Living With Skin Diseases: Here’s How a Hidradenitis Suppurativa Diagnosis Will Impact ...
While it’s not true that hidradenitis suppurativa is caused by poor hygiene, what you do in the shower can worsen flare-ups ...
BioSpace
1 天
AstraZeneca, Amgen Claim Late-Stage Win in Chronic Rhinosinusitis but Analyst Flags ...
The companies did not provide detailed data for Tezspire, however, and William Blair’s Matt Phipps said in a note he does not ...
FiercePharma
4 天
AstraZeneca, Amgen's Tezspire scores in rhinosinusitis study
Six months after Amgen and AstraZeneca reported promising results for Tezspire (t | A phase 3 study has shown that ...
BioPharma Dive
4 天
Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value
AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...
EuropaWire
4 天
Tezspire Shows Promise in Reducing Nasal Polyp Symptoms in Phase III Trial for Chronic ...
17,18 TSLP is released in response to multiple triggers (including allergens, viruses and other airborne particles) ...
4 天
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
AstraZeneca Plc (NASDAQ:AZN) and Amgen Inc (NASDAQ:AMGN) released topline data from the Phase 3 WAYPOINT trial of Tezspire ...
4 天
TEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH ...
Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈